Ondine Biomedical Inc.
OBIMF
$0.11
-$0.02-15.39%
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -10.54M | -10.64M | -10.68M | -12.27M | -13.98M |
| Total Depreciation and Amortization | 417.80K | 427.50K | 434.90K | 425.20K | 417.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | 489.90K | 999.60K |
| Total Other Non-Cash Items | 242.10K | 297.20K | 348.80K | 462.90K | 581.20K |
| Change in Net Operating Assets | 603.90K | 189.40K | -222.40K | -146.20K | -59.30K |
| Cash from Operations | -9.27M | -9.73M | -10.12M | -11.04M | -12.04M |
| Capital Expenditure | -9.60K | -70.70K | -131.30K | -145.70K | -160.70K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -9.60K | -70.70K | -131.30K | -145.70K | -160.70K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -440.00K | -433.50K | -427.00K | -376.00K | -325.00K |
| Issuance of Common Stock | 10.97M | 7.94M | 4.91M | 2.46M | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.25M | -975.00K | -700.00K | -350.00K | 0.00 |
| Cash from Financing | 6.85M | 4.84M | 2.80M | 1.29M | -242.20K |
| Foreign Exchange rate Adjustments | 58.40K | -3.90K | -66.00K | 86.90K | 246.30K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.37M | -4.96M | -7.52M | -9.80M | -12.20M |
